Aphea.Bio NV

Bio NV, founded in 2017, operates from Ghent, Belgium, and specializes in developing microbial solutions for agriculture.9 million.Bio specializes in the development of biocontrol and biostimulant products aimed at promoting sustainable agriculture. The company utilizes its innovative APEXbio™ R&D platform to harness the diversity of microorganisms, creating natural alternatives to chemical pesticides and synthetic fertilizers. Key product categories include advanced biostimulants and biofungicides, with notable products in the pipeline such as bioherbicides and bioinsecticides.Bio serves a diverse clientele in the agricultural sector, including farmers and distributors, by offering solutions that enhance crop yield and health across various segments, particularly cereals.Bio generates revenue through the direct sale of its microbial-based agricultural products, including its flagship offerings, VALORIA™ and VIRTUOSA™, which are biofungicides currently undergoing regulatory approval. The company's transaction structure operates predominantly on a B2B model, providing products directly to agricultural businesses and distributors rather than through general retail channels. Pricing plans for these products are structured based on volume and specific client agreements, allowing flexibility in procurement for large-scale agricultural operations.60.Bio™ for maize in the US and Brazil. The expansion efforts target these two significant agricultural markets to enhance their product offerings and market reach.

1. Series C

   Jul 27, 2023

   Amount

   $48M

   Investors

   Locked

2. Series B

   Oct 21, 2020

   Amount

   $21M

   Investors

   Locked

3. Series A

   Jun 29, 2017

   Amount

   $8.4M

   Investors

   Locked